150 related articles for article (PubMed ID: 17611713)
1. Production of angiogenic factors by human glioblastoma cells following activation of the G-protein coupled formylpeptide receptor FPR.
Yao XH; Ping YF; Chen JH; Chen DL; Xu CP; Zheng J; Wang JM; Bian XW
J Neurooncol; 2008 Jan; 86(1):47-53. PubMed ID: 17611713
[TBL] [Abstract][Full Text] [Related]
2. [Activation of formylpeptide receptor in human malignant glioma cells and its effects on cell proliferation and production of angiogenic factors].
Yao XH; Bian XW; Ping YF; Chen JH; Wang QL; Jiang XF
Ai Zheng; 2007 Mar; 26(3):241-6. PubMed ID: 17355784
[TBL] [Abstract][Full Text] [Related]
3. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas.
Zhou Y; Bian X; Le Y; Gong W; Hu J; Zhang X; Wang L; Iribarren P; Salcedo R; Howard OM; Farrar W; Wang JM
J Natl Cancer Inst; 2005 Jun; 97(11):823-35. PubMed ID: 15928303
[TBL] [Abstract][Full Text] [Related]
4. [Nordy inhibits cell proliferation and angiogenic factor production of malignant human glioma cells mediated by formylpeptide receptor].
Yao XH; Ping YF; Bian XW; Chen JH; Wang QL; Jiang XF
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(7):479-84. PubMed ID: 17459229
[TBL] [Abstract][Full Text] [Related]
5. [Effect of nordy on FPR function of malignant human glioma cell line U87].
Chen JH; Bian XW; Yao XH; Yang SX; Xu CR; Zhou XD; Ping YF
Yao Xue Xue Bao; 2007 Mar; 42(3):257-62. PubMed ID: 17520823
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma stem cells produce vascular endothelial growth factor by activation of a G-protein coupled formylpeptide receptor FPR.
Yao XH; Ping YF; Chen JH; Xu CP; Chen DL; Zhang R; Wang JM; Bian XW
J Pathol; 2008 Aug; 215(4):369-76. PubMed ID: 18523971
[TBL] [Abstract][Full Text] [Related]
7. Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells.
Huang J; Hu J; Bian X; Chen K; Gong W; Dunlop NM; Howard OM; Wang JM
Cancer Res; 2007 Jun; 67(12):5906-13. PubMed ID: 17575160
[TBL] [Abstract][Full Text] [Related]
8. The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells.
Huang J; Chen K; Chen J; Gong W; Dunlop NM; Howard OM; Gao Y; Bian XW; Wang JM
Br J Cancer; 2010 Mar; 102(6):1052-60. PubMed ID: 20197768
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the leucocyte chemoattractant receptor FPR in glioblastoma cells by cell differentiation.
Huang J; Chen K; Huang J; Gong W; Dunlop NM; Howard OM; Bian X; Gao Y; Wang JM
Carcinogenesis; 2009 Feb; 30(2):348-55. PubMed ID: 19037090
[TBL] [Abstract][Full Text] [Related]
10. Downregulating FPR restrains xenograft tumors by impairing the angiogenic potential and invasive capability of malignant glioma cells.
Chen DL; Ping YF; Yu SC; Chen JH; Yao XH; Jiang XF; Zhang HR; Wang QL; Bian XW
Biochem Biophys Res Commun; 2009 Apr; 381(3):448-52. PubMed ID: 19233142
[TBL] [Abstract][Full Text] [Related]
11. Nordy, a synthetic lipoxygenase inhibitor, inhibits the expression of formylpeptide receptor and induces differentiation of malignant glioma cells.
Chen JH; Bian XW; Yao XH; Gong W; Hu J; Chen K; Iribarren P; Zhao W; Zhou XD
Biochem Biophys Res Commun; 2006 Apr; 342(4):1368-74. PubMed ID: 16516855
[TBL] [Abstract][Full Text] [Related]
12. [Activation of CXCR4 in human glioma stem cells promotes tumor angiogenesis].
Ping YF; Yao XH; Bian XW; Chen JH; Zhang R; Yi L; Zhou ZH
Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):179-83. PubMed ID: 17535685
[TBL] [Abstract][Full Text] [Related]
13. A novel lipoxygenase inhibitor Nordy attenuates malignant human glioma cell responses to chemotactic and growth stimulating factors.
Chen JH; Yao XH; Gong W; Hu J; Zhou XD; Chen K; Liu H; Ping YF; Wang JM; Bian XW
J Neurooncol; 2007 Sep; 84(3):223-31. PubMed ID: 17377739
[TBL] [Abstract][Full Text] [Related]
14. The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis.
Prevete N; Liotti F; Visciano C; Marone G; Melillo RM; de Paulis A
Oncogene; 2015 Jul; 34(29):3826-38. PubMed ID: 25263443
[TBL] [Abstract][Full Text] [Related]
15. Biologically active peptides interacting with the G protein-coupled formylpeptide receptor.
Le Y; Wang JM; Liu X; Kong Y; Hou X; Ruan L; Mou H
Protein Pept Lett; 2007; 14(9):846-53. PubMed ID: 18045224
[TBL] [Abstract][Full Text] [Related]
16. Human malignant glioma cells expressing functional formylpeptide receptor recruit endothelial progenitor cells for neovascularization.
Xu CP; Zhang HR; Chen FL; Yao XH; Liang ZQ; Zhang R; Cui Y; Qian C; Bian XW
Int Immunopharmacol; 2010 Dec; 10(12):1602-7. PubMed ID: 20933627
[TBL] [Abstract][Full Text] [Related]
17. Sesamin inhibits bacterial formylpeptide-induced inflammatory responses in a murine air-pouch model and in THP-1 human monocytes.
Cui Y; Hou X; Chen J; Xie L; Yang L; Le Y
J Nutr; 2010 Feb; 140(2):377-81. PubMed ID: 20032476
[TBL] [Abstract][Full Text] [Related]
18. The green tea polyphenol (-)-epigallocatechin-3-gallate inhibits leukocyte activation by bacterial formylpeptide through the receptor FPR.
Zhu J; Wang O; Ruan L; Hou X; Cui Y; Wang JM; Le Y
Int Immunopharmacol; 2009 Aug; 9(9):1126-30. PubMed ID: 19426837
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of U-87 human glioblastoma cell proliferation and formyl peptide receptor function by oligomer procyanidins (F2) isolated from grape seeds.
Zhang FJ; Yang JY; Mou YH; Sun BS; Ping YF; Wang JM; Bian XW; Wu CF
Chem Biol Interact; 2009 May; 179(2-3):419-29. PubMed ID: 19167369
[TBL] [Abstract][Full Text] [Related]
20. The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8.
Fu H; Bylund J; Karlsson A; Pellmé S; Dahlgren C
Immunology; 2004 Jun; 112(2):201-10. PubMed ID: 15147563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
